Literature DB >> 16095686

Reduced thrombogenicity of nitinol stents--in vitro evaluation of different surface modifications and coatings.

Gunnar Tepe1, Joerg Schmehl, Hans P Wendel, Sivio Schaffner, Stephan Heller, Marc Gianotti, Claus D Claussen, Stephan H Duda.   

Abstract

The material and the surface patterns of intravascular stents play a pivotal role in activating platelets and triggering adherence of inflammatory cells that consecutively leads to renarrowing caused by neointimal hyperplasia. To improve these features, besides mechanical and chemical modifications, ways of masking the stent by covering have been developed. In addition, polymer-coated stents are used as vehicle for local drug delivery. But as substances used for this application are described to possess an inflammatory potential, this aspect has to be evaluated. In the present study we compared different approaches to surface alterations applied to a nitinol stent design. Besides commonly used techniques like passivation and electropolishing, we evaluated coatings with heparin, aluminium and a polyurethane polymer regarding their thrombogenic and inflammatory characteristics. By weaving thin elastomer fibres a graft was generated. The previously described Chandler loop was used to simulate arterial flow conditions ex vivo using rotating PVC tubings filled with human blood. All stents received 120 min of blood contact. To determine thrombocyte activation and inflammatory reaction, the platelet count and levels of beta-TG, TAT and PMN-elastase were assessed. Scanning electron microscopy was used to visualize the reactions. Mechanical polishing and passivation did not improve the stent surface characteristics while sandblasting, electropolishing and aluminium covering decreased activation of the coagulation cascade. In terms of thrombogenicity, the heparin coating had no beneficial effect. The lowest thrombogenic potential was found in the Polyurethane-coated stent group. All stents showed similar levels of polymorph nuclear granulocyte elastase except for the membrane design. While mechanical and chemical modifications are able to reduce thrombogenicity, coating with this particular polyurethane polymer seems to be superior to these approaches regarding the parameters assessed in this experimental setting. The Chandler loop is a valuable tool to test polymeric coatings ex vivo since these modifications may reduce drug performance by inducing inflammatory reaction themselves.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095686     DOI: 10.1016/j.biomaterials.2005.06.004

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  17 in total

1.  A novel ovine ex vivo arteriovenous shunt model to test vascular implantability.

Authors:  Haofan Peng; Evan M Schlaich; Sindhu Row; Stelios T Andreadis; Daniel D Swartz
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

2.  Effects of micro-magnetic field at the surface of 316L and NiTi alloy on blood compatibility.

Authors:  Qiang Liu; Xiao Nong Cheng; Huang Xia Fei
Journal:  Med Biol Eng Comput       Date:  2010-10-09       Impact factor: 2.602

3.  Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces.

Authors:  Zhilu Yang; Xin Zhao; Rui Hao; Qiufen Tu; Xiaohua Tian; Yu Xiao; Kaiqing Xiong; Miao Wang; Yonghai Feng; Nan Huang; Guoqing Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

4.  Cytotoxicity of Ni from Surface-Treated Porous Nitinol (PNT) on Osteoblast Cells.

Authors:  C Pulletikurthi; N Munroe; P Gill; S Pandya; D Persaud; W Haider; K Iyer; A McGoron
Journal:  J Mater Eng Perform       Date:  2011-07-01       Impact factor: 1.819

5.  NiTi superelastic orthodontic archwires with polyamide coating.

Authors:  L A Bravo; A González de Cabañes; J M Manero; E Rúperez; F Javier Gil
Journal:  J Mater Sci Mater Med       Date:  2013-10-24       Impact factor: 3.896

Review 6.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

7.  The role of stents in the treatment of congenital heart disease: Current status and future perspectives.

Authors:  Bjoern Peters; Peter Ewert; Felix Berger
Journal:  Ann Pediatr Cardiol       Date:  2009-01

8.  Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial.

Authors:  Gunnar Tepe; Rüdiger Bantleon; Klaus Brechtel; Jörg Schmehl; Thomas Zeller; Claus D Claussen; Frederik F Strobl
Journal:  Eur Radiol       Date:  2012-05-10       Impact factor: 5.315

9.  NCO-sP(EO-stat-PO) coatings on gold sensors--a QCM study of hemocompatibility.

Authors:  Stefan Sinn; Mirjam Eichler; Lothar Müller; Daniel Bünger; Jürgen Groll; Gerhard Ziemer; Frank Rupp; Hinnak Northoff; Jürgen Geis-Gerstorfer; Frank K Gehring; Hans P Wendel
Journal:  Sensors (Basel)       Date:  2011-05-13       Impact factor: 3.576

Review 10.  Obstacles in haemocompatibility testing.

Authors:  W van Oeveren
Journal:  Scientifica (Cairo)       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.